Exciting News: we just released a 92% pure CBG extract – cannabigerol – from hemp!
While it’s not an incredible feat of science to have extracted this compound, we certainly feel it is a game changer for our industry and company. We believe that the launch of this product will create ripples that inspire other cannabis companies to innovate, and inquisitive people across the world to research the many amazing cannabinoids and compounds in the hemp plant.
When we released our first CBD product in 2013, barely anyone knew what it was. At the time, we were one of three companies in the nation selling that type of product on a nationwide and global scale. Now, three and a half years later there are hundreds of “CBD companies” in the USA. While the release of our CBG may not have quite the same impact, we are confident it will make a substantial one. To the best of our knowledge, we are the very first US consumer brand to release a CBG product!
Cannabigerol (CBG) in its acidic form (CBG-A) is the “parent cannabinoid” in cannabis from which all the other cannabinoids are derived. Currently, it’s extremely rare for most hemp cultivars to contain any significant amount of CBG by the time of maturation, as the genetics of most hemp plants signal them to convert cannabigerol, via enzymatic action, into the many other cannabinoids. Nonetheless, we have sourced a unique cultivar that has a relatively high amount of cannabigerol come maturation, and we’ve created a 92% pure CBG extract from it.
In the near future, under our new Bluebird Endo line, we will be releasing a +96% pure Oleamide, which is a major human endocannabinoid that was derived from olive oil’s oleic acid (an omega-9 fatty acid). Stay tuned for more!